Your browser doesn't support javascript.
loading
Rituximab Monotherapy or in Combination with Bendamustine Is Not Inferior to Rituximab-CHOP Regimen in the Treatment of Patients with Splenic Marginal Zone Lymphoma in the Real Life.
Mulas, Olga; Caocci, Giovanni; Dessì, Daniela; Mantovani, Daniela; Moi, Giulia; Cabras, Maria Giuseppina; La Nasa, Giorgio.
Affiliation
  • Mulas O; Ematologia e CTMO, Ospedale Businco, AOB, Cagliari, Italy.
  • Caocci G; Dipartimento di Scienze Mediche e Sanità Pubblica, Università di Cagliari, Cagliari, Italy.
  • Dessì D; Ematologia e CTMO, Ospedale Businco, AOB, Cagliari, Italy, giovanni.caocci@unica.it.
  • Mantovani D; Dipartimento di Scienze Mediche e Sanità Pubblica, Università di Cagliari, Cagliari, Italy, giovanni.caocci@unica.it.
  • Moi G; Ematologia e CTMO, Ospedale Businco, AOB, Cagliari, Italy.
  • Cabras MG; Dipartimento di Scienze Mediche e Sanità Pubblica, Università di Cagliari, Cagliari, Italy.
  • La Nasa G; Ematologia e CTMO, Ospedale Businco, AOB, Cagliari, Italy.
Acta Haematol ; 144(3): 322-326, 2021.
Article in En | MEDLINE | ID: mdl-32892194
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Lymphoma, B-Cell, Marginal Zone / Bendamustine Hydrochloride / Rituximab Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Lymphoma, B-Cell, Marginal Zone / Bendamustine Hydrochloride / Rituximab Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2021 Type: Article